Costa, Helena
Touma, Joel
Davoudi, Belghis
Benard, Melinda
Sauer, Torill
Geisler, Jürgen
Vetvik, Katja
Rahbar, Afsar http://orcid.org/0000-0003-1158-2512
Söderberg-Naucler, Cecilia
Funding for this research was provided by:
BILTEMA Foundation
Nexttobe
Stichting af Jochnicks
Sten A Olssons Stiftelse för Forskning och Kultur
Familjen Erling-Perssons Foundation
RATOS
independent grants from Hoffmann La Roche
Torsten and Ragnar Söderbergs Foundations
Swedish Cancer Foundation
Swedish Medical Research Council
Svenska Sällskapet för Medicinsk Forskning
Stiftelsen Sigurd and Elsa Goljes Minne
Magnus Bergvalls Foundation
Swedish Society for Medical Research
Percy Falks Foundation
Karolinska Institutet
IngaBritt och Arne Lundbergs Foundation
Tore Nilsons Foundation
the regional health administration (Helse Sør-Øst),
internal research funds of Akerhus University Hospital
Bodil and Magne´s Cancer Research Fund
Dan och Jane Olssons Foundation
Article History
Received: 26 March 2019
Accepted: 27 May 2019
First Online: 15 June 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest and that the results presented in this paper have not been published previously. This cohort of breast cancer patients was previously investigated for HCMV protein expression and association with estrogen receptor-alpha (ER) and progesterone receptor (PGR) expression and the results were reported earlier (Rahbar et al. CitationRef removed).
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All patients gave their written informed consent prior to inclusion. The study protocol was approved by the regional ethical committee of south-east Norway, Oslo, Norway (2008/628-31/2, 577-06-04148, 06118 and 2014/895) and by the ethical committee at the Karolinska Institutet (Dnr: 2008/628-31/2), Stockholm, Sweden. Placental tissues were obtained after informed parental consent and according to the procedures approved by the Regulations of the French Ministry of Health.